{
    "clinical_study": {
        "@rank": "60464", 
        "arm_group": {
            "arm_group_label": "Single Arm", 
            "arm_group_type": "Experimental", 
            "description": "Daily watching videos using Reviview\u2122, a dichoptic video display device"
        }, 
        "brief_summary": {
            "textblock": "The study will evaluate the effect of Reviview\u2122, a dichoptic video display device for\n      administrating a novel treatment protocol for Amblyopia (lazy eye) in kids.\n\n      The effect of the treatment will be measured by the change from baseline in Visual acuity\n      and in Stereoscopic Vision; and to assess the ease of use of and compliance by the patients."
        }, 
        "brief_title": "Assessment of Device for Treatment of Amblyopia", 
        "condition": "Amblyopia", 
        "condition_browse": {
            "mesh_term": "Amblyopia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Refractive or Strabismic Amblyopia, with best corrected visual acuity.\n\n        (1) Refractive Amblyopia, visual acuity score  <6:15 (worse then)\n\n          -  or (2) Strabismic Amblyopia, visual acuity score  between 6:15 and 6:30\n\n        Exclusion Criteria:\n\n        Diagnosed with epilepsy, recently treated with occlusion or penalization therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "8 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003235", 
            "org_study_id": "RV-TMSC-1"
        }, 
        "intervention": {
            "arm_group_label": "Single Arm", 
            "intervention_name": "Daily watching  videos using Reviview\u2122, a dichoptic video display device, for 60 min", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "Amblyopia", 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "contact": {
                "last_name": "Gili Lavi, coordinator", 
                "phone": "+972-3-6974361"
            }, 
            "facility": {
                "address": {
                    "city": "Tel-Aviv", 
                    "country": "Israel"
                }, 
                "name": "Tel-Aviv Sourasky Medical Center"
            }, 
            "investigator": {
                "last_name": "Chaim Stolovitch, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "last_name": "Chaim Stolovitch, MD", 
            "phone": "+972-3-6974361"
        }, 
        "overall_official": {
            "affiliation": "Tel-Aviv Sourasky Medical Center", 
            "last_name": "Haim Stolovitch, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Israel: Ethics Commission", 
                "Israel: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Improvement in VA in amblyopic eye", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003235"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Visior Technologies Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Visior Technologies Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}